舊藥新用：首款FDA核准藥物藉由抑制IRAK4及其訊息傳遞途徑達到抗發炎之效用

標題:	舊藥新用：首款FDA核准藥物藉由抑制IRAK4及其訊息傳遞途徑達到抗發炎之效用 Drug repurposing: the first FDA drug inhibits IRAK4 and pathways for anti-inflammation
作者:	沈培鈞 Shen, Pei-Chun 楊進木 Yang, Jinn-Moon 生物資訊及系統生物研究所
關鍵字:	舊藥新用;蛋白質激酶抑制劑;抗發炎反應;同源藥理;Drug repurposing;Protein kinase inhibitor;Anti-inflammation;Homopharma
公開日期:	2015
URI:	http://140.113.39.130/cdrfb3/record/nctu/#GT070257206 http://hdl.handle.net/11536/127154
Appears in Collections:	Thesis